Skip to main content
Premium Trial:

Request an Annual Quote

Finnzymes and Sage Science to Develop for Upstream and Downstream Analysis of PCR and qPCR Apps

This article updates an earlier version that incorrectly reported that the companies are co-developing PCR instruments.
 
NEW YORK (GenomeWeb News) — Finnzymes Instruments yesterday said it plans to use “core competencies” from Sage Science to develop a line of programmable instruments to be used in “key processes upstream and downstream analysis of PCR and qPCR applications.”
Finnzymes vice president of operations Mike Mortillaro said the company expects the new line of products will “complement” Finnzymes’ line of thermal cyclers and its expected real-time PCR instruments.
 
Financial terms of the agreement were not released.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.